Other health services
ULLENSVANG VAKSINEKLINIKK AS
Revenue 2025
NOK 391,000
Operating profit
NOK 19,000
Equity
NOK 29,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2025
Current ratio
1.75
Equity ratio
56.2%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 5.0% | |
| Net margin (%%) | 5.0% | |
| Return on assets (%%) | 38.1% | |
| Likviditet | ||
| Current ratio | 1.75 | |
| Working capital | 16k | |
| Soliditet | ||
| Equity ratio (%%) | 56.2% | |
| Debt-to-equity ratio | 0.78 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.